A Study to Evaluate the Efficacy and Safety of Brivaracetam in Study Participants (>=16 to 80 Years of Age) With Epilepsy

NCT03083665 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

449

Enrollment

INDUSTRY

Sponsor class

Conditions

Partial Seizures With or Without Secondary Generalization
Epilepsy

Interventions

DRUG: Placebo
DRUG: Brivaracetam

Sponsor

UCB Biopharma SRL